ArticleVaccine2022

Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment.

Pedro M Folegatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.